The supplements work through different pathways without interfering with each other's absorption or effectiveness
Benefits Sleep regulation studied for promoting deeper, more restorative sleep phases Stress response linked to modulation of stress-related neuroendocrine activity Circadian rhythm balance explored for normalizing disrupted sleepwake cycles Recovery support interest in improved resilience and recovery in fatigue models Neuromodulation early research suggests possible interactions with opioid and NMDA pathways Localized Effects with Nasal Spray Rapid uptake through the nasal mucosa Direct modulation of sleep-related neuropeptide and stress-response pathways Formulated with a specialized isotonic nasal vehicle to minimize irritation and dryness What Researchers Use It For Regulation of sleep architecture, delta-wave activity, and circadian rhythms Interaction with corticotropin and stress hormone pathways Modulation of opioid peptide activity and pain-related signaling Potential antioxidant and neuroprotective roles in preclinical models Identity & Specs Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu Formula / M.W.: C35H48N10O15, ~848.8 g/mol CAS: 62568-57-4 Form: Sterile nasal spray solution Net per vial: 10 mL (~100 sprays) Total Content: 5 mg DSIP per vial Purity: 99% (HPLC) Identity: MS-verified (per COA) Storage: 28 C, protect from light Selected Research PubChem entry chemical identity & registry: Original discovery (1977) isolation and initial findings: Sleep studies review DSIP in sleep regulation: Neuroendocrine effects corticotropin and stress hormone pathways: Disclaimer This product is intended for laboratory research use only
Further research is required, particularly large-scale meticulously planned clinical trials, to definitively determine their safety, optimal efficacy, and appropriate dosage regimens
It helps brighten skin tone, reduce pigmentation, and support collagen synthesis while providing daily UV protection and anti-ageing benefits
These symptoms may indicate complications requiring investigation rather than symptomatic treatment alone
The next major step in this therapeutic evolution is the addition of glucagon receptor activation
